Decentralized Trials: Considerations for Building a New Patient-Centric Model
Graciela Racaro, Global Head of Operations for Parexel Biotech, discusses the advances we have seen in the past year towards a more patient-centric environment.
Learn More
Decentralized Clinical Trials
The future of clinical trials is now
-
-
Decentralized clinical trials - A more patient-centric approach
Decentralized clinical trials, where portions of a study are conducted outside a traditional trial site, offer new opportunities — and new hope — for patients struggling with inflammatory conditions.
Read More
-
Four Keys to a Smoother Clinical Development Journey
Whitepaper recently published in Fierce Biotech providing perspectives on how the right partner can help bring all the disciplines together for a successful development program.
Read More
-
eBook: Innovating for the future of drug development
In this eBook, Parexel subject matter experts speak to some of the exciting trends that are moving the industry toward the drug development of the future.
Read More
-
Loading, please wait
Error - something went wrong!
Let's start a conversation...
Thank you! We'll be in touch soon.
-
Top Ten Rules for Success in DCTs
Patients’ needs and insights are central to how we design and conduct trials. Here are our top ten rules for a successful DCT...
Read More
-
COVID19 The Great Decentralized Clinical Trials Accelerator
Learn more from Roz Round, Parexel’s Vice President, Patient Innovation Center about how Decentralized Clinical Trials can help ensure patient safety and enable ongoing trial participation.
Read More
-
The future is now: Decentralized clinical trials during the pandemic and beyond
Enabling patients to participate in clinic trials from home is both important to maintain patient safety and data quality in ongoing trials and critical for many new trials as we plan for COVID-19.
Learn More
-
The Parexel Podcast | Episode 10: The emerging role of wearables in clinical trials
The COVID-19 pandemic has forced us to rethink just about every aspect of clinical trials. An area of significant potential is the use of wearables as part of Decentralized Clinical Trials (DCTs)....
Learn More
-
Industry Perspectives on Decentralized Clinical Trials
Parexel commissioned independent research to identify biopharmaceutical industry perspectives on the benefits and barriers of Decentralized Clinical Trials...
Read More
-
The future of clinical trials is now: Decentralized Clinical Trials
Parexel’s Decentralized Clinical Trials represent an opportunity to rethink and refresh how research studies are conducted.
Read More
-
Decentralized Clinical Trials and Patient Needs
Trishna Bharadia shares her daily living experience managing multiple sclerosis with Parexel’s Rosamund Round and Amanda Knaggs.
Watch Video
